Machine learning tool sets out to find new antimicrobial peptides
IBM researchers say their fully automated AI-driven system could speed up the discovery of molecules for novel antibiotics
By combining machine learning, molecular dynamics simulations and experiments it has been possible to design antimicrobial peptides from scratch.1 The approach is an important advance in a field where data is scarce and trial-and-error design is expensive and slow, the team say.